Related Experiment Video

Updated: Sep 23, 2026

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
05:04

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations

Published on: February 2, 2024

Stem cell therapy for cerebral palsy

John Bartley1, James E Carroll

  • 1Department of Pediatrics of the Medical College of Georgia, Augusta, Georgia, USA.

Expert Opinion on Biological Therapy
|July 2, 2003
PubMed

Insights

Stem cell therapy shows promise for treating cerebral palsy (CP), a chronic childhood motor disability. Animal studies suggest intravascular transplantation is feasible, paving the way for human trials.

Area of Science:

  • Neurology
  • Regenerative Medicine
  • Pediatrics

Background:

  • Cerebral palsy (CP) encompasses chronic motor disabilities in children, stemming from diverse causes including developmental abnormalities and birth-related injuries.
  • The incidence of CP may be rising due to increased survival rates of very premature infants.
  • Neonatal hypoxic-ischaemic (HI) injury in infants, though a minority cause of CP, significantly impacts oligodendrocytes and cerebral white matter.

Purpose of the Study:

  • To explore the potential of stem cell therapy for cerebral palsy (CP).
  • To evaluate the feasibility of intravascular stem cell transplantation for neurological disorders.
  • To identify key variables for future human clinical trials in CP.

Main Methods:

  • Review of existing literature on stem cell therapy in neurological disorders.
  • Analysis of animal studies involving experimentally induced strokes and traumatic brain injuries.
  • Consideration of variables for human trials, including cell type, transplant timing, and functional outcomes.

Main Results:

  • Stem cell therapy presents a promising avenue for CP treatment.
  • Animal models with induced injuries indicate potential therapeutic benefits from stem cells.
  • Intravascular transplantation offers a less invasive delivery method compared to direct brain injection.

Conclusions:

  • While no controlled human trials for CP exist, animal data supports further investigation.
  • Systematic studies in animal models of HI injury are crucial for optimizing stem cell therapy.
  • The findings support the translation of intravascular stem cell transplantation to human trials for cerebral palsy.

More Related Videos

GM-Free Generation of Blood-Derived Neuronal Cells08:11

GM-Free Generation of Blood-Derived Neuronal Cells

Published on: February 13, 2021

Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells09:29

Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells

Published on: July 10, 2019

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...